Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,303
Closed -$962K 332
2025
Q2
$962K Sell
2,303
-5,834
-72% -$2.18M ﹤0.01% 894
2025
Q1
$2.91M Buy
8,137
+2,852
+54% +$1.23M 0.01% 657
2024
Q4
$2.28M Buy
5,285
+152
+3% +$62.3K 0.01% 730
2024
Q3
$1.97M Buy
5,133
+923
+22% +$352K 0.01% 755
2024
Q2
$1.85M Buy
+4,210
New +$1.82M 0.01% 775
2023
Q2
Sell
-3,000
Closed -$923K 1104
2023
Q1
$923K Sell
3,000
-3,400
-53% -$1.21M ﹤0.01% 879
2022
Q4
$2.07M Sell
6,400
-400
-6% -$130K 0.01% 772
2022
Q3
$1.85M Buy
+6,800
New +$1.8M 0.01% 769

Other funds holding DDS

Axa's DDS Position: Q3 2025 in Review

Axa sold out of Dillards (DDS) in Q3 2025, closing a stake of 2,303 shares — an estimated $962K sold.

Axa first reported a position in DDS in Q3 2022 and held it in 8 quarters. The position peaked at $2.91M in Q1 2025. 293 funds tracked by Wall St. Rank hold DDS as of Q3 2025.

  • Axa reported no remaining Dillards position as of Q3 2025 after selling out during the quarter.
  • Axa sold 2,303 Dillards shares in Q3 2025, an estimated $962K.
  • Axa first reported a position in Dillards in Q3 2022 and held it in 8 quarters.
  • Axa's Dillards position peaked at $2.91M in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Dillards as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.